The University of Chicago Header Logo

Connection

Nitasha Sarswat to Humans

Back to Details
This is a "connection" page, showing publications Nitasha Sarswat has written about Humans.
Nitasha Sarswat
Connection Strength
0.478
Humans
  1. Impact of Tafamidis on Survival in a Real-World Community-Based Cohort. Curr Probl Cardiol. 2022 Dec; 47(12):101358.
    View in: PubMed
    Score: 0.025
  2. An Orphan Disease No More: Additional Treatment Options for Cardiac Amyloidosis. J Card Fail. 2020 09; 26(9):760-761.
    View in: PubMed
    Score: 0.022
  3. Valvular heart disease. FP Essent. 2012 Jun; 397:1-6, 9-39; quiz 7-8, 40-3.
    View in: PubMed
    Score: 0.012
  4. Cardiogenic shock. Hosp Pract (1995). 2010 Feb; 38(1):74-83.
    View in: PubMed
    Score: 0.010
  5. Hypersensitivity myocarditis associated with azithromycin exposure. Ann Intern Med. 2009 Feb 03; 150(3):225-6.
    View in: PubMed
    Score: 0.010
  6. Cardiac amyloidosis detection from a single echocardiographic video clip: a novel artificial intelligence-based screening tool. Eur Heart J. 2025 10 22; 46(40):4090-4101.
    View in: PubMed
    Score: 0.008
  7. Disparities in diagnosis and outcomes in American patients with transthyretin cardiac amyloidosis. Int J Cardiovasc Imaging. 2025 Aug; 41(8):1487-1496.
    View in: PubMed
    Score: 0.008
  8. Early Increase in Serum Transthyretin by Acoramidis Independently Predicts Improved Survival in TTR Amyloid Cardiomyopathy. J Am Coll Cardiol. 2025 May 27; 85(20):1911-1923.
    View in: PubMed
    Score: 0.007
  9. Mitigating Post-operative Right Ventricular Dysfunction After Left Ventricular Assist Device: The RV Protection Study. J Card Fail. 2026 Jan; 32(1):46-57.
    View in: PubMed
    Score: 0.007
  10. Early and Late Outcomes of Ambulatory Counter Pulsation Devices as a Bridge to Heart Transplantation. Cardiology. 2025; 150(4):381-388.
    View in: PubMed
    Score: 0.007
  11. Long-Term Efficacy and Safety of Acoramidis in ATTR-CM: Initial Report From the Open-Label Extension of the ATTRibute-CM Trial. Circulation. 2025 Mar 04; 151(9):601-611.
    View in: PubMed
    Score: 0.007
  12. Perivascular Amyloid Deposition in Immunoglobulin Light Chain Cardiac Amyloidosis and Its Implications on Echocardiographic Cardiac Remodeling. J Am Soc Echocardiogr. 2024 Oct; 37(10):1010-1012.
    View in: PubMed
    Score: 0.007
  13. Defining echocardiographic predictors of outcome in cardiac amyloidosis by subtype. Curr Probl Cardiol. 2024 Sep; 49(9):102729.
    View in: PubMed
    Score: 0.007
  14. Limitations of apical sparing pattern in cardiac amyloidosis: a multicentre echocardiographic study. Eur Heart J Cardiovasc Imaging. 2024 05 31; 25(6):754-761.
    View in: PubMed
    Score: 0.007
  15. Prevalence of valvular heart disease in cardiac amyloidosis and impact on survival. Curr Probl Cardiol. 2024 Apr; 49(4):102417.
    View in: PubMed
    Score: 0.007
  16. Patisiran Treatment in Patients with Transthyretin Cardiac Amyloidosis. N Engl J Med. 2023 10 26; 389(17):1553-1565.
    View in: PubMed
    Score: 0.007
  17. Impact of prophylactic donor heart tricuspid valve annuloplasty on outcomes in heart transplantation. J Cardiothorac Surg. 2023 Oct 12; 18(1):288.
    View in: PubMed
    Score: 0.007
  18. Preservation of Circumferential and Radial Left Ventricular Function as a Mitigating Mechanism for Impaired Longitudinal Strain in Early Cardiac Amyloidosis. J Am Soc Echocardiogr. 2023 12; 36(12):1290-1301.
    View in: PubMed
    Score: 0.007
  19. Non-invasive diagnosis of transthyretin cardiac amyloidosis utilizing typical late gadolinium enhancement pattern on cardiac magnetic resonance and light chains. Eur Heart J Cardiovasc Imaging. 2023 05 31; 24(6):829-837.
    View in: PubMed
    Score: 0.007
  20. Vascular Amyloid Deposition Is Highly Prevalent in Immunoglobulin Light Chain Cardiac Amyloidosis. JACC Cardiovasc Imaging. 2023 08; 16(8):1121-1123.
    View in: PubMed
    Score: 0.006
  21. Status One and Status Two Exception Use in the Updated Heart Allocation System. J Card Fail. 2023 06; 29(6):963-967.
    View in: PubMed
    Score: 0.006
  22. Serum amyloidosis: a cardiac amyloidosis. Eur Heart J Cardiovasc Imaging. 2023 03 21; 24(4):e59.
    View in: PubMed
    Score: 0.006
  23. The prognostic role of advanced hemodynamic variables in patients with left ventricular assist devices. Artif Organs. 2023 Mar; 47(3):574-581.
    View in: PubMed
    Score: 0.006
  24. 99m Technetium-pyrophosphate bone scan: A potential biomarker for the burden of transthyretin amyloidosis in skeletal muscle: A preliminary study. Muscle Nerve. 2023 Feb; 67(2):111-116.
    View in: PubMed
    Score: 0.006
  25. Clinical outcomes of grafted vs. percutaneous axillary intra-aortic balloon pump support as a bridge to transplantation: a propensity score-matched analysis. Heart Vessels. 2022 Dec; 37(12):1995-2001.
    View in: PubMed
    Score: 0.006
  26. Comparing short-term/long-term outcomes of heart transplants that occur inside and outside of normal working hours. ESC Heart Fail. 2022 08; 9(4):2484-2490.
    View in: PubMed
    Score: 0.006
  27. Prevalence of Right Atrial Impairment and Association with Outcomes in Cardiac Amyloidosis. J Am Soc Echocardiogr. 2022 08; 35(8):829-835.e1.
    View in: PubMed
    Score: 0.006
  28. Progressive Multiple Mononeuropathy in a Patient With Familial Transthyretin Amyloidosis After Liver Transplantation. J Clin Neuromuscul Dis. 2022 Mar 01; 23(3):143-147.
    View in: PubMed
    Score: 0.006
  29. Significant vascular complications in percutaneous axillary intra-aortic balloon pump. Ann Vasc Surg. 2022 Jul; 83:42-52.
    View in: PubMed
    Score: 0.006
  30. Continuous Remote Patient Monitoring: Evaluation of the Heart Failure Cascade Soft Launch. Appl Clin Inform. 2021 10; 12(5):1161-1173.
    View in: PubMed
    Score: 0.006
  31. Expert opinion on monitoring symptomatic hereditary transthyretin-mediated amyloidosis and assessment of disease progression. Orphanet J Rare Dis. 2021 10 03; 16(1):411.
    View in: PubMed
    Score: 0.006
  32. Proximal ascending aorta size is associated with the incidence of de novo aortic insufficiency with left ventricular assist device. Heart Vessels. 2022 Apr; 37(4):647-653.
    View in: PubMed
    Score: 0.006
  33. Aortic Pulsatility Index: A Novel Hemodynamic Variable for Evaluation of Decompensated Heart Failure. J Card Fail. 2021 10; 27(10):1045-1052.
    View in: PubMed
    Score: 0.006
  34. Discordance between lactic acidemia and hemodynamics in patients with advanced heart failure. Clin Cardiol. 2021 May; 44(5):636-645.
    View in: PubMed
    Score: 0.006
  35. Aortic pulsatility index predicts clinical outcomes in heart failure: a sub-analysis of the ESCAPE trial. ESC Heart Fail. 2021 04; 8(2):1522-1530.
    View in: PubMed
    Score: 0.006
  36. Increased Rate of Pump Thrombosis and Cardioembolic Events Following Ventricular Tachycardia Ablation in Patients Supported With Left Ventricular Assist Devices. ASAIO J. 2020 Nov/Dec; 66(10):1127-1136.
    View in: PubMed
    Score: 0.005
  37. Outcomes of Ambulatory Axillary Intraaortic Balloon Pump as a Bridge to Heart Transplantation. Ann Thorac Surg. 2021 04; 111(4):1264-1270.
    View in: PubMed
    Score: 0.005
  38. Early experience of COVID-19 in 2 heart transplant recipients: Case reports and review of treatment options. Am J Transplant. 2020 10; 20(10):2916-2922.
    View in: PubMed
    Score: 0.005
  39. Short-Term Efficacy and Safety of Tolvaptan in Patients with Left Ventricular Assist Devices. ASAIO J. 2020 03; 66(3):253-257.
    View in: PubMed
    Score: 0.005
  40. Estimation of Central Venous Pressure by Pacemaker Lead Impedances in Left Ventricular Assist Device Patients. ASAIO J. 2020 01; 66(1):49-54.
    View in: PubMed
    Score: 0.005
  41. Combined Left Ventricular Assist Device and Coronary Artery Bypass Grafting Surgery: Should We Bypass the Bypass? ASAIO J. 2020 01; 66(1):32-37.
    View in: PubMed
    Score: 0.005
  42. Surgical device exchange provides improved clinical outcomes compared to medical therapy in treating continuous-flow left ventricular assist device thrombosis. Artif Organs. 2020 Apr; 44(4):367-374.
    View in: PubMed
    Score: 0.005
  43. Metabolic Dysfunction in Continuous-Flow Left Ventricular Assist Devices Patients and Outcomes. J Am Heart Assoc. 2019 11 19; 8(22):e013278.
    View in: PubMed
    Score: 0.005
  44. Discordance Between Clinical Assessment and Invasive Hemodynamics in Patients With Advanced Heart Failure. J Card Fail. 2020 Feb; 26(2):128-135.
    View in: PubMed
    Score: 0.005
  45. Association of Inflow Cannula Position with Left Ventricular Unloading and Clinical Outcomes in Patients with HeartMate II Left Ventricular Assist Device. ASAIO J. 2019 May/Jun; 65(4):331-335.
    View in: PubMed
    Score: 0.005
  46. A subcostal approach is favorable compared to sternotomy for left ventricular assist device exchange field of research: artificial heart (clinical). J Artif Organs. 2019 Sep; 22(3):181-187.
    View in: PubMed
    Score: 0.005
  47. The Effects of Hemodynamic Unloading in African Americans Implanted with Left Ventricular Assist Devices. ASAIO J. 2019 02; 65(2):e15-e17.
    View in: PubMed
    Score: 0.005
  48. Impact of Cardiac Resynchronization Therapy on Left Ventricular Unloading in Patients with Implanted Left Ventricular Assist Devices. ASAIO J. 2019 02; 65(2):117-122.
    View in: PubMed
    Score: 0.005
  49. Outflow Cannula Systolic Slope in Patients With Left Ventricular Assist Devices: A Novel Marker of Myocardial Contractility. ASAIO J. 2019 02; 65(2):160-166.
    View in: PubMed
    Score: 0.005
  50. Optimal Hemodynamics During Left Ventricular Assist Device Support Are Associated With Reduced Readmission Rates. Circ Heart Fail. 2019 02; 12(2):e005094.
    View in: PubMed
    Score: 0.005
  51. Home Inotropes in Patients Supported with Left Ventricular Assist Devices. ASAIO J. 2019 01; 65(1):e7-e11.
    View in: PubMed
    Score: 0.005
  52. Optimal haemodynamics during left ventricular assist device support are associated with reduced haemocompatibility-related adverse events. Eur J Heart Fail. 2019 05; 21(5):655-662.
    View in: PubMed
    Score: 0.005
  53. A histopathologic schema to quantify the burden of cardiac amyloidosis: Relationship with survival and echocardiographic parameters. Echocardiography. 2019 02; 36(2):285-291.
    View in: PubMed
    Score: 0.005
  54. Relationship Between Noninvasive Assessment of Lung Fluid Volume and Invasively Measured Cardiac Hemodynamics. J Am Heart Assoc. 2018 11 20; 7(22):e009175.
    View in: PubMed
    Score: 0.005
  55. Improvement in Biventricular Cardiac Function After Ambulatory Counterpulsation. J Card Fail. 2019 Jan; 25(1):20-26.
    View in: PubMed
    Score: 0.005
  56. Repeated Ramp Tests on Stable LVAD Patients Reveal Patient-Specific Hemodynamic Fingerprint. ASAIO J. 2018 Nov/Dec; 64(6):701-707.
    View in: PubMed
    Score: 0.005
  57. Omega-3 Therapy Is Associated With Reduced Gastrointestinal Bleeding in Patients With Continuous-Flow Left Ventricular Assist Device. Circ Heart Fail. 2018 10; 11(10):e005082.
    View in: PubMed
    Score: 0.005
  58. Impact of Residual Valve Disease on Survival After Implantation of Left Ventricular Assist Devices. Ann Thorac Surg. 2018 12; 106(6):1789-1796.
    View in: PubMed
    Score: 0.005
  59. Decoupling Between Diastolic Pulmonary Arterial Pressure and Pulmonary Arterial Wedge Pressure at Incremental Left Ventricular Assist Device (LVAD) Speeds Is Associated With Worse Prognosis After LVAD Implantation. J Card Fail. 2018 Sep; 24(9):575-582.
    View in: PubMed
    Score: 0.005
  60. Echocardiographic Predictors of Hemodynamics in Patients Supported With Left Ventricular Assist Devices. J Card Fail. 2018 Sep; 24(9):561-567.
    View in: PubMed
    Score: 0.005
  61. Increase in short-term risk of rejection in heart transplant patients receiving granulocyte colony-stimulating factor. J Heart Lung Transplant. 2018 11; 37(11):1322-1328.
    View in: PubMed
    Score: 0.005
  62. Increased Risk of Bleeding in Left Ventricular Assist Device Patients Treated with Enoxaparin as Bridge to Therapeutic International Normalized Ratio. ASAIO J. 2018 Mar/Apr; 64(2):140-146.
    View in: PubMed
    Score: 0.005
  63. Long-Acting Octreotide Reduces the Recurrence of Gastrointestinal Bleeding in Patients With a Continuous-Flow Left Ventricular Assist Device. J Card Fail. 2018 Apr; 24(4):249-254.
    View in: PubMed
    Score: 0.005
  64. Predictors of Hemodynamic Improvement and Stabilization Following Intraaortic Balloon Pump Implantation in Patients With Advanced Heart Failure. J Invasive Cardiol. 2018 02; 30(2):56-61.
    View in: PubMed
    Score: 0.004
  65. Consequences of Retained Defibrillator and Pacemaker Leads After Heart Transplantation-An Underrecognized Problem. J Card Fail. 2018 02; 24(2):101-108.
    View in: PubMed
    Score: 0.004
  66. HVAD Waveform Analysis as a Noninvasive Marker of Pulmonary Capillary Wedge Pressure: A First Step Toward the Development of a Smart Left Ventricular Assist Device Pump. ASAIO J. 2018 Jan/Feb; 64(1):10-15.
    View in: PubMed
    Score: 0.004
  67. Cannula and Pump Positions Are Associated With Left Ventricular Unloading and Clinical Outcome in Patients With HeartWare Left Ventricular Assist Device. J Card Fail. 2018 03; 24(3):159-166.
    View in: PubMed
    Score: 0.004
  68. Decoupling Between Diastolic Pulmonary Artery Pressure and Pulmonary Capillary Wedge Pressure as a Prognostic Factor After Continuous Flow Ventricular Assist Device Implantation. Circ Heart Fail. 2017 Sep; 10(9).
    View in: PubMed
    Score: 0.004
  69. Cardiac Output Assessment in Patients Supported with Left Ventricular Assist Device: Discordance Between Thermodilution and Indirect Fick Cardiac Output Measurements. ASAIO J. 2017 Jul/Aug; 63(4):433-437.
    View in: PubMed
    Score: 0.004
  70. The Hemodynamic Effects of Aortic Insufficiency in Patients Supported With Continuous-Flow Left Ventricular Assist Devices. J Card Fail. 2017 Jul; 23(7):545-551.
    View in: PubMed
    Score: 0.004
  71. 3D Morphological Changes in LV and RV During LVAD Ramp Studies. JACC Cardiovasc Imaging. 2018 02; 11(2 Pt 1):159-169.
    View in: PubMed
    Score: 0.004
  72. Surgically Corrected Mitral Regurgitation During Left Ventricular Assist Device Implantation Is Associated With Low Recurrence Rate and Improved Midterm Survival. Ann Thorac Surg. 2017 Mar; 103(3):725-733.
    View in: PubMed
    Score: 0.004
  73. Plasma Serotonin in Heart Failure: Possible Marker and Potential Treatment Target. Heart Lung Circ. 2017 May; 26(5):442-449.
    View in: PubMed
    Score: 0.004
  74. Left Ventricular Assist Device Deactivation via Percutaneous Closure of the Outflow Graft. J Card Fail. 2016 Aug; 22(8):653-5.
    View in: PubMed
    Score: 0.004
  75. Screening for Outflow Cannula Malfunction of Left Ventricular Assist Devices (LVADs) With the Use of Doppler Echocardiography: New LVAD-Specific Reference Values for Contemporary Devices. J Card Fail. 2016 Oct; 22(10):808-14.
    View in: PubMed
    Score: 0.004
  76. Novel echocardiographic parameters of aortic insufficiency in continuous-flow left ventricular assist devices and clinical outcome. J Heart Lung Transplant. 2016 08; 35(8):976-85.
    View in: PubMed
    Score: 0.004
  77. Hemodynamic Ramp Tests in Patients With Left Ventricular Assist Devices. JACC Heart Fail. 2016 Mar; 4(3):208-17.
    View in: PubMed
    Score: 0.004
  78. Cutaneous and cardiac myxomas in a patient with carney complex. Am J Med. 2012 Oct; 125(10):e9-e10.
    View in: PubMed
    Score: 0.003
  79. Association between endothelial function and chronotropic incompetence in subjects with chronic heart failure receiving optimal medical therapy. Echocardiography. 2010 Mar; 27(3):294-9.
    View in: PubMed
    Score: 0.003
  80. Interdependence of cardiac and endothelial function in patients with symptomatic chronic heart failure of nonischemic etiology. Echocardiography. 2009 Sep; 26(8):916-21.
    View in: PubMed
    Score: 0.002
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.